<DOC>
	<DOCNO>NCT02234336</DOCNO>
	<brief_summary>Assessment wall thickness hypertrophic cardiomyopathy ( HCM ) diagnostic prognostic importance give know association sudden cardiac death . However , data regard comparison image modality key measurement lacking . This study seek compare assessment maximum wall thickness clinically indicate echocardiography ( without contrast ) clinically indicated cardiac magnetic resonance imaging .</brief_summary>
	<brief_title>Assessment Wall Thickness Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description>Patients receive clinically indicate echocardiograms cardiac magnetic resonance image Mayo Clinic eligible .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>1 . Clinically echocardiographically define hypertrophic cardiomyopathy . 2 . Clinically indicated transthoracic echocardiography part medical evaluation . 3 . No contradiction administration ultrasonic echocardiography contrast . 4 . Planned clinically indicated cardiac magnetic resonance image part medical evaluation . 5 . No contraindication cardiac magnetic resonance imaging ( cochlear implant , central nervous system aneurysm clip implant medical device ) . 6 . Age 18 year old 1 ) Insufficient image quality determination maximal wall thickness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Echocardiography</keyword>
	<keyword>hypertrophic cardiomyopathy</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>contrast</keyword>
</DOC>